Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yizhuang International Protein Pharmaceutical Technology is a biotechnology company based in the Beijing Economic-Technological Development Area (E-Town). The company specializes in the research, development, and industrialization of recombinant protein drugs and monoclonal antibodies. It operates as a comprehensive service platform providing CRO and CDMO services, including protein expression, purification process development, and pilot-scale production. The company's core mission is to accelerate the translation of laboratory-scale protein research into clinical-grade therapeutic products through its advanced technology platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Yizhuang International Protein Pharmaceutical Technology.